| scholarly article | Q13442814 |
| P2093 | author name string | Junichiro Mizuguchi | |
| Noriko Morishima | |||
| Takayuki Yoshimoto | |||
| Toshiyuki Owaki | |||
| Fumio Fukai | |||
| Sadahiro Kamiya | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3871-3877 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells | |
| P478 | volume | 173 |
| Q34071264 | A novel mechanism of skin tumor promotion involving interferon-gamma (IFNγ)/signal transducer and activator of transcription-1 (Stat1) signaling |
| Q37747078 | A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes |
| Q39029629 | A review on interleukins: The key manipulators in rheumatoid arthritis |
| Q37606436 | Activation of IL-27 signalling promotes development of postinfluenza pneumococcal pneumonia |
| Q36922033 | Apoptotic tumor cells induce IL-27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity |
| Q35038440 | Association of IL-27 gene three polymorphisms with Crohn's disease susceptibility in a Chinese Han population |
| Q27014743 | Biology of IL-27 and its role in the host immunity against Mycobacterium tuberculosis |
| Q39534409 | Characterization and functional analyses of a novel chicken CD8α variant X1 (CD8α1). |
| Q37377041 | Contribution of IL-12R mediated feedback loop to Th1 cell differentiation |
| Q47552661 | Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo |
| Q46411431 | Differential antitumor effect of interleukin-12 family cytokines on orthotopic hepatocellular carcinoma |
| Q36421693 | Diverse inflammatory cytokines induce selectin ligand expression on murine CD4 T cells via p38α MAPK. |
| Q33687042 | Diversity and Plasticity of Th Cell Types Predicted from Regulatory Network Modelling |
| Q39158943 | Dual Roles of IL-27 in Cancer Biology and Immunotherapy |
| Q80809164 | Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation |
| Q43215219 | Elevated Circulating Levels of Inflammatory Markers in Patients with Acute Coronary Syndrome |
| Q44955344 | Expression of IL-27, Th1 and Th17 in Patients with Aplastic Anemia |
| Q35050165 | Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period. |
| Q38976165 | Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC). |
| Q33754839 | Genome-Wide Analyses of MicroRNA Profiling in Interleukin-27 Treated Monocyte-Derived Human Dendritic Cells Using Deep Sequencing: A Pilot Study. |
| Q33801032 | High Interleukin 27 Production is Associated with Early Clinical Stage and Localized Disease in Patients with Melanoma |
| Q37649577 | Humanin and the receptors for humanin |
| Q34989661 | IFN-gamma-inducing transcription factor, T-bet is upregulated by estrogen in murine splenocytes: role of IL-27 but not IL-12 |
| Q36417195 | IFN-γ limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27 |
| Q37349766 | IL-12 family members in experimental colitis |
| Q39430580 | IL-27 Enhances LPS-Induced Proinflammatory Cytokine Production via Upregulation of TLR4 Expression and Signaling in Human Monocytes |
| Q36177032 | IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling |
| Q36861764 | IL-27 Promotes Proliferation of Human Leukemic Cell Lines Through the MAPK/ERK Signaling Pathway and Suppresses Sensitivity to Chemotherapeutic Drugs |
| Q35122668 | IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation |
| Q37294477 | IL-27 attenuates airway inflammation in a mouse asthma model via the STAT1 and GADD45γ/p38 MAPK pathways |
| Q35025256 | IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner |
| Q38073078 | IL-27 in tumor immunity and immunotherapy |
| Q36694200 | IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation |
| Q56900809 | IL-27 inhibits the development of regulatory T cells via STAT3 |
| Q34581324 | IL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization |
| Q44868708 | IL-27 promotes nitric oxide production induced by LPS through STAT1, NF-κB and MAPKs |
| Q83756687 | IL-27 suppresses RANKL expression in CD4+ T cells in part through STAT3 |
| Q64261877 | IL-27 targets Foxp3+ Tregs to mediate antiinflammatory functions during experimental allergic airway inflammation |
| Q89928899 | IL-27p28 Production by XCR1+ Dendritic Cells and Monocytes Effectively Predicts Adjuvant-Elicited CD8+ T Cell Responses |
| Q57158134 | IL-27p28 is essential for parent-to-F1 acute graft-versus-host disease |
| Q37426283 | Impact of placental Plasmodium falciparum malaria infection on the Cameroonian maternal and neonate's plasma levels of some cytokines known to regulate T cells differentiation and function |
| Q26825342 | Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes |
| Q35592657 | Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27. |
| Q57093711 | Influenza infection directly alters innate IL-23 and IL-12p70 and subsequent IL-17A and IFN-γ responses to pneumococcus in vitro in human monocytes |
| Q35461764 | Interferon-β suppresses murine Th1 cell function in the absence of antigen-presenting cells |
| Q55365932 | Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes. |
| Q28395500 | Interleukin 12 a key immunoregulatory cytokine in infection applications |
| Q80102518 | Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system |
| Q37668153 | Interleukin-27 Enhances the Potential of Reactive Oxygen Species Generation from Monocyte-derived Macrophages and Dendritic cells by Induction of p47phox |
| Q91691723 | Interleukin-27 Is Essential for Type 1 Diabetes Development and Sjögren Syndrome-like Inflammation |
| Q39666166 | Interleukin-27 acts on hepatic stellate cells and induces signal transducer and activator of transcription 1-dependent responses |
| Q39338555 | Interleukin-27 and interleukin-12 augment activation of distinct cord blood natural killer cells responses via STAT3 pathways |
| Q39828171 | Interleukin-27 displays interferon-gamma-like functions in human hepatoma cells and hepatocytes |
| Q27022577 | Interleukin-27 in T cell immunity |
| Q37334618 | Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon |
| Q40101857 | Interleukin-27 signalling induces stem cell antigen-1 expression in T lymphocytes in vivo |
| Q34242185 | Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus |
| Q37792908 | Interleukin-27: biological properties and clinical application. |
| Q38087644 | Interleukin-35: The Future of Hyperimmune-Related Diseases? |
| Q37073886 | Interleukin-35: odd one out or part of the family? |
| Q37773302 | Interleukins and cancer immunotherapy. |
| Q37600191 | Intestinal effector T cells in health and disease. |
| Q91945340 | Intra-Tumoral Delivery of IL-27 Using Adeno-Associated Virus Stimulates Anti-tumor Immunity and Enhances the Efficacy of Immunotherapy |
| Q36703585 | Life and death in the granuloma: immunopathology of tuberculosis |
| Q92199134 | Mucosal T follicular helper cells in SIV-infected rhesus macaques: contributing role of IL-27 |
| Q35134457 | Mutations in the transmembrane and juxtamembrane domains enhance IL27R transforming activity |
| Q36184396 | New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions |
| Q37001149 | New complexities in helper T cell fate determination and the implications for autoimmune diseases |
| Q36969873 | New therapies for sepsis: focus on the interleukin (IL)12 family member IL27 |
| Q35642774 | Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27. |
| Q37231755 | PPAR Regulation of Inflammatory Signaling in CNS Diseases |
| Q37120690 | Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance. |
| Q52145132 | Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses. |
| Q39991590 | Prolactin can modulate CD4+ T-cell response through receptor-mediated alterations in the expression of T-bet |
| Q42767187 | Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. |
| Q40508641 | Regulation and Immune Function of IL-27. |
| Q37795583 | Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. |
| Q42129243 | Regulation of defense responses against protozoan infection by interleukin-27 and related cytokines |
| Q37735773 | Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS. |
| Q41887169 | Signaling Events Involved in Interleukin 27 (IL-27)-induced Proliferation of Human Naive CD4+ T Cells and B Cells |
| Q36137937 | TIR Domain-Containing Adapter-Inducing Beta Interferon (TRIF) Mediates Immunological Memory against Bacterial Pathogens |
| Q35105613 | Tailored immune responses: novel effector helper T cell subsets in protective immunity |
| Q36422101 | Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection. |
| Q36740433 | Th17 cell induction and immune regulatory effects. |
| Q34756202 | The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses. |
| Q93158307 | The Immunobiology of the Interleukin-12 Family: Room for Discovery |
| Q36733744 | The biology and therapeutic potential of interleukin 27. |
| Q37099883 | The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte response |
| Q33627048 | The role of STAT3 and AhR in the differentiation of CD4+ T cells into Th17 and Treg cells |
| Q39796152 | The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses |
| Q37747271 | Thymic DCs derived IL-27 regulates the final maturation of CD4(+) SP thymocytes |
| Q37021803 | Transcriptional regulation of Th17 cell differentiation |
| Q24676526 | Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor |
| Q33750852 | Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27 |
| Q33895262 | WSX1 Expression in Tumors Induces Immune Tolerance via Suppression of Effector Immune Cells |
Search more.